Topics discussed during the VT/VF/Heart Failure Summit included mechanism of VT, heritable diseases of cardiac rhythm, what’s new in 2010, EP approach to the heart failure patient in the era of VADs, and primary ICD therapy in young patients.
VT/VF/Heart Failure Summit Interviews
The VT/VF/Heart Failure Summit at Heart Rhythm 2010 was supported via
an unrestricted educational grant
provided by Medtronic
The VT/VF/Heart Failure Summit took place on May 12, 2010. E. Kevin Heist, MD, Ph.D., Massachusetts General Hospital Heart Center, interviews the following Summit faculty:
ICD Therapy in Young Patients— William J. Groh, MD, Krannert Institute of Cardiology, Indianapolis, IN discusses the challenges of defibrillator therapy in young patients. Watch Groh interview now (5:56) »
VT: From Basic Physiology to Clinical Management— Alfred E. Buxton, MD, Brown Medical School, Providence, RI evaluates VT including basic mechanism and clinical management strategies. Watch Buxton interview now (6:27) »
Heritable Diseases of Cardiac Rhythm: What is New in 2010?— Christine M. Albert, MD, Brigham and Women’s Hospital, Boston, MA provides an update in genetic advances and their role in understanding and managing heritable arrhythmic syndromes producing VT/VF and SCD. Watch Albert interview now (5:01) »
EP Approach to the Heart Failure Patient in the Era of Ventricular Assist Devices (VADs)— Lynne W. Stevenson, MD, Brigham and Women’s Hospital, Boston, MA discusses the benefits and limitations of VADs and managing patients with them. Watch Stevenson interview now (5:25) »
